Proglumide

丙谷胺

Report date: 2022/05/27 12:20:51
NME

Base Information

Drug NameProglumide
Drug Alias Name二丙谷酰胺proglumidumProMilidPromid +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin receptors antagonists
TargetsCholecystokinin receptors
Therapy Area/IndicationsPainPancreatic DiseasesLiver Cirrhosis +[8] 
Global Approved IndicationsStomach UlcerDuodenal UlcerGastritis +[4] 
Approved Indications in ChinaStomach UlcerDuodenal UlcerGastritis +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGeorgetown UniversityYichang Humanwell Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPainPancreatic DiseasesLiver Cirrhosis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BX06
Related LinksWikipediaKEGG